Discontinuation report OCTOSTIM LIQ INJ. 15MCG/ML
Report ID | 138144 |
Drug Identification Number | 02024179 |
Brand name | OCTOSTIM LIQ INJ. 15MCG/ML |
Common or Proper name | Desmopressin Acetate Injection |
Company Name | FERRING INC |
Market Status | MARKETED |
Active Ingredient(s) | DESMOPRESSIN ACETATE |
Strength(s) | 15MCG |
Dosage form(s) | LIQUID SOLUTION |
Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
Packaging size | Cartons of 10 ampoules |
ATC code | H01BA |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-04-30 |
Actual discontinuation date | 2021-04-29 |
Remaining supply date | 2021-04-29 |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | 15 mcg stock anticipated to deplete by 30-Apr-2021 |
Company comments | For patients, please discuss alternative treatment options with your health care professional. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-07-08 | French | Compare |
v9 | 2021-07-08 | English | Compare |
v8 | 2021-04-30 | English | Compare |
v7 | 2021-04-29 | French | Compare |
v6 | 2021-04-29 | English | Compare |
v5 | 2021-04-27 | English | Compare |
v4 | 2021-04-27 | French | Compare |
v3 | 2021-04-27 | French | Compare |
v2 | 2021-04-27 | English | Compare |
v1 | 2021-04-27 | English | Compare |
Showing 1 to 10 of 10